Company news: AstraZeneca, Roche

Share this article:
In a drive to preserve its Crestor market share, AstraZeneca said it is picking up the difference between the cost of the generic and its branded statin in Canada, where Mylan got the okay for a copycat launch in March. Although AZ rolled out a co-pay card in February, the effort garnered fresh attention today with Ontario's announcement that the generic and brand are interchangeable on that province's market. Canadian provinces individually determine formulary parity. The cards are supplied and processed by STI Technologies, which told MM&M that Ontario is its biggest prescription market.

In a sign that the deepening EU financial crisis is putting stress on hospital dispensaries, Roche is now demanding hospitals in Spain and Portugal pay down their debts if they want to receive more medications, reported Bloomberg. This latest move by the Swiss drugmaker is part of the larger debt crisis narrative. Several locations were already on the pay-to-play list as of last year, but the latest change is that the number of hospitals on this list has continued to grow. Roche now requires several Greek hospitals to pay for drugs before delivery, according to Bloomberg.
Share this article:
close

Next Article in Business Briefs

Email Newsletters

More in Business Briefs

Penn and Teller give take on vaccines

The Las Vegas twosome give the anti-vaccination movement their signature treatment.

GSK allegations build in Jordan and Lebanon

GlaxoSmithKline says it is investigating allegations of employee misconduct. The company said in a statement that the allegations have numbers "very similar to those reported by other companies in our sector."

Generic Celebrex is coming

Pfizer and Teva's settlement puts generic Celebrex on the market by December.